| Condition | Key Finding | Association | Board Exam Tip |
| G6 PD Deficiency | Heinz bodies; bite cells | Oxidative stress (sulfa drugs, fava beans) | Remember the classic demographics: Mediterranean/African descent. |
| Acute Mesenteric Ischemia | Left upper quadrant pain; pulseless bowel | Embolus from A Fib -> LAA thrombus to SMA | The most common occluded vessel is the Superior Mesenteric Artery (SMA). |
| Spontaneous Bacterial Peritonitis (SBP) | PMN count > 250/mL in ascites fluid | Chronic liver disease, portal hypertension | Treat empirically with a third-generation cephalosporin. |
| AAA Rupture Workup | Pulsatile abdominal mass; hemodynamic instability | Immediate surgical emergency | If unstable AND pulsatile mass is present, skip imaging and go straight to the OR. |
| Topic | Key Point | Context | Exam Relevance |
| G6 PD Deficiency | Autosomal recessive; HMP shunt defect | Oxidative stress (sulfa drugs) | Test for G6 PD levels after the inciting event, as acute levels may be normal. |
| Pre-renal AKI | Low U Na+ (<20); BUN:Cr < 20:1 | Hypovolemia/cardiorenal syndrome | Treatment is volume expansion (fluids). |
| AAA Rupture Workup | Stable patient with pulsatile mass | CTA is appropriate for initial diagnosis. | Unstable patient requires immediate surgical intervention, bypassing imaging. |
| Cirrhosis Stigmata | Spider angiomata, testicular atrophy, gynecomastia | Hyperestrogenism (due to impaired estrogen metabolism) | These findings point toward chronic liver failure/portal hypertension. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| Young male with history of Mediterranean descent taking sulfa drugs develops hemolytic anemia, low haptoglobin, and Heinz bodies on smear. | G6 PD Deficiency | Oxidative stress triggers hemolysis; classic demographics (Mediterranean/African) are key clues. |
| A patient presents with acute severe abdominal pain, a pulsatile mass, and hemodynamic instability. | Ruptured AAA | This is an immediate surgical emergency requiring rapid intervention to prevent death. |
| An elderly alcoholic patient develops jaundice, spider angiomata, testicular atrophy, and ascites. | Cirrhosis/Portal Hypertension | These stigmata are classic signs of chronic liver failure due to portal hypertension. |
| A 35-year-old Uber driver presents with oliguria, elevated creatinine (from baseline), and history of CTA contrast administration. | Contrast Nephropathy / AKI | The use of iodinated contrast media is a common cause of intrinsic AKI. |
| A patient develops jaundice and has an MRCP showing "beads on a string" appearance in the bile ducts. | Primary Sclerosing Cholangitis (PSC) | PSC involves stricturing/destruction of both intra- and extrahepatic biliary ducts. |
| An alcoholic male presents with macrocytic anemia, elevated GGT, and signs of chronic liver disease. | Alcoholic Liver Disease / Hemochromatosis | Elevated AST:ALT ratio (>2:1) and high GGT are specific markers for alcohol-related liver injury. |
| Key Features | Distinguishing Findings | Next Step |
| Pre-renal AKI | Low U Na+ (<20); BUN:Cr < 20:1; Urine Osmolality < 1.0 mOsm/kg. | Fluid resuscitation (IV crystalloids). |
| Contrast Nephropathy | History of CTA contrast use; Intrinsic AKI. | Supportive care; prevent recurrence with adequate hydration. |
| Acute Interstitial Nephritis (AIN) | Triad: Fever, rash, eosinophilia; Drug-induced (e.g., anti-streptococcal penicillins). | Stop the offending agent; steroids if refractory. |
| Post-renal AKI | Obstruction (BPH, stones); Urine labs may appear pre-renal initially. | Interventional relief of obstruction (catheterization, lithotripsy). |
| Key Features | Distinguishing Findings | Next Step |
| Primary Sclerosing Cholangitis (PSC) | Destruction of intra- AND extrahepatic ducts; "Beads on a string" appearance. | Surveillance for colorectal cancer; treat with Ursodiol if PBC is suspected. |
| Primary Biliary Cholangitis (PBC) | Destruction of intrahepatic bile ducts only; Anti-mitochondrial antibodies (AMA) positive. | Treat with Ursodiol and monitor for progression. |
| Wilson's Disease | Copper metabolism defect; Low ceruloplasmin; Kayser-Fleischer rings. | Chelation therapy (D-penicillamine, Trientine). |
| Condition | Association | Mechanism | Clinical Significance |
| G6 PD Deficiency | Oxidative stress; Sulfa drugs, fava beans | Failure to regenerate reduced glutathione (via HMP shunt). | Leads to acute intravascular hemolysis and potential life-threatening anemia. |
| AAA Rupture | Smoking; Hypertension | Degradation of elastin/collagen in the aortic media by increased Matrix Metalloproteinase (MMP) activity. | Screening guidelines exist for high-risk individuals (e.g., smoking history). |
| Cirrhosis Stigmata | Spider angiomata, testicular atrophy, gynecomastia | Hyperestrogenism due to impaired estrogen metabolism in the liver. | These findings are strong indicators of chronic hepatic failure. |
| Acute Mesenteric Ischemia | Atrial Fibrillation; SMA occlusion | Embolus formation from LAA thrombus leading to bowel necrosis. | Requires immediate surgical/interventional management and often leads to septic shock. |
| Term | Definition | Context | Example |
| HMP Shunt | Hexose Monophosphate Pathway (Pentose Phosphate Pathway) | Provides reducing power (NADPH) necessary for glutathione synthesis. | Deficiency in this pathway causes G6 PD deficiency and susceptibility to oxidative stress. |
| SAAG Gradient | Serum Albumin - Ascitic Fluid Albumin | Differentiates the cause of ascites fluid protein leakage. | A gradient > 1.1 suggests portal hypertension; < 1.1 suggests malignancy/peritonitis. |
| Eculizumab | Monoclonal antibody targeting C5 complement component. | Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). | Blocks the formation of the Membrane Attack Complex (MAC), preventing hemolysis. |
| Octreotide | Somatostatin analog; synthetic hormone. | Acute variceal bleeding management. | Reduces portal venous flow and splanchnic vasoconstriction, lowering portal pressure. |
| Topic | Study Approach | Priority | Resources |
| Hemolytic Anemias | Create a differential table comparing key findings (smear, labs, triggers). | High | Review classic demographics and specific diagnostic tests (e.g., acidified glycerol lysis test for HS). |
| AKI & Nephrotoxins | Categorize AKI by mechanism (pre-, intrinsic, post-renal) and list associated nephrotoxins/causes. | Medium-High | Focus on the physiological markers (U Na+, BUN:Cr ratio) to differentiate pre-renal states. |
| Cirrhosis & GI Bleeding | Master the pathophysiology of portal hypertension and common complications (SBP, varices). | High | Memorize the specific treatments for SBP (ceftriaxone) and variceal bleeding (octreotide/PP Is). |
🚫Mistake 2: Misinterpreting SAAG Gradient. Remember that a gradient > 1.1 suggests portal hypertension (e.g., cirrhosis), while < 1.1 suggests non-portal causes like malignancy or peritonitis.
🚫Mistake 3: Assuming all AKI is Pre-renal. Always perform urine studies (U Na+, Urine Osmolality) to differentiate between pre-renal, intrinsic, and post-renal causes of AKI.
⚠️Trap 3: The "Alcoholic Liver Disease" Trap: While AST:ALT > 2:1 and high GGT are suggestive, remember that the underlying mechanism for stigmata (spider angiomata) is hyperestrogenism, not just alcohol consumption itself.